CT Guided Injection for Low Back Radiculopathy: A Randomized Clinical Trial

NCT ID: NCT01267825

Last Updated: 2018-08-31

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE4

Total Enrollment

1 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-09-01

Study Completion Date

2013-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Herniated disc sometimes cause back pain radiating down to a leg. This pain can be so severe that it is functionally disabling. The purpose of this randomized clinical trial is to determine if corticosteroid medication, delivered directly to the area near the herniated disc, can improve the pain and functional disability associated with a herniated disc.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Disc Herniation Lumbosacral Radiculopathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CT-guided intervention

CT guided perineural injection of corticosteroid+ bupivicaine Also get typical medical care

Group Type EXPERIMENTAL

CT-guided corticosteroid+ bupivicaine

Intervention Type DRUG

CT-guided corticosteroid+ bupivicaine Also get standard medical care

Standard medical care

Group Type ACTIVE_COMPARATOR

Standard medical care

Intervention Type DRUG

Naproxen + Oxycodone/ Acetaminophen

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CT-guided corticosteroid+ bupivicaine

CT-guided corticosteroid+ bupivicaine Also get standard medical care

Intervention Type DRUG

Standard medical care

Naproxen + Oxycodone/ Acetaminophen

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults \<60y
* \< 1m of symptoms
* Symptoms consistent with herniated disc
* MRI demonstrates corresponding disc
* Back pain resulting in functional disability

Exclusion Criteria

* Chronic pain
* Daily pain medication
* Frequent back pain
* On the job injury
Minimum Eligible Age

21 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Montefiore Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Benjamin W. Friedman, MD

Prof. Emergency Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Todd Miller, MD

Role: PRINCIPAL_INVESTIGATOR

Montefiore Medical Center

Benjamin W. Friedman, MD, MS

Role: PRINCIPAL_INVESTIGATOR

Montefiore Medical Center/Albert Einstein College of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Montefiore Medical Center

The Bronx, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

10-06-162

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

FLO for Discogenic Pain
NCT03644251 TERMINATED NA